Puma Biotechnology Inc (PBYI) - Financial and Strategic SWOT Analysis Review

  • ID: 4278708
  • SWOT Analysis
  • 41 pages
  • GlobalData
  • Puma Biotechnology Inc
1 of 5

FEATURED COMPANIES

  • Corcept Therapeutics Inc
  • Fate Therapeutics Inc
  • MORE
Puma Biotechnology Inc (PBYI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Puma Biotechnology Inc (Puma) is a biopharmaceutical company that develops novel therapeutics for the treatment of cancer. The company develops and commercializes three drug candidates, namely, PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Its pipeline portfolio also encompasses investigational candidates for various indications such as adjuvant breast cancer, gastric cancer, metastatic breast cancer, and HER2-positive breast cancer, among others. Puma in-licenses its drug candidates and advances its development through clinical testing and for commercial use. Puma is headquartered in Los Angeles, California, the US.

Puma Biotechnology Inc Key Recent Developments

May 09, 2018: Puma Biotechnology Reports First Quarter 2018 Financial Results
Mar 01, 2018: Puma Biotechnology Announces Fourth Quarter and Full Year 2017 Financial Results
Dec 14, 2017: Puma Biotechnology Added to NASDAQ Biotechnology Index
Nov 09, 2017: Puma Biotechnology Reports Third Quarter 2017 Financial Results
Aug 09, 2017: Puma Biotechnology Reports Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Corcept Therapeutics Inc
  • Fate Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Puma Biotechnology Inc - Key Facts
  • Puma Biotechnology Inc - Key Employees
  • Puma Biotechnology Inc - Key Employee Biographies
  • Puma Biotechnology Inc - Major Products and Services
  • Puma Biotechnology Inc - History
  • Puma Biotechnology Inc - Company Statement
  • Puma Biotechnology Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Puma Biotechnology Inc - Business Description
  • Puma Biotechnology Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Puma Biotechnology Inc - Strengths
  • Puma Biotechnology Inc - Weaknesses
  • Puma Biotechnology Inc - Opportunities
  • Puma Biotechnology Inc - Threats
  • Puma Biotechnology Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Puma Biotechnology Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 09, 2018: Puma Biotechnology Reports First Quarter 2018 Financial Results
  • Dec 14, 2017: Puma Biotechnology Added to NASDAQ Biotechnology Index
  • Nov 09, 2017: Puma Biotechnology Reports Third Quarter 2017 Financial Results
  • Aug 09, 2017: Puma Biotechnology Reports Second Quarter 2017 Financial Results
  • May 10, 2017: Puma Biotechnology Reports First Quarter 2017 Financial Results
  • Mar 01, 2017: Puma Biotechnology Reports Fourth Quarter and Full Year 2016 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Puma Biotechnology Inc, Key Facts
  • Puma Biotechnology Inc, Key Employees
  • Puma Biotechnology Inc, Key Employee Biographies
  • Puma Biotechnology Inc, Major Products and Services
  • Puma Biotechnology Inc, History
  • Puma Biotechnology Inc, Subsidiaries
  • Puma Biotechnology Inc, Key Competitors
  • Puma Biotechnology Inc, Ratios based on current share price
  • Puma Biotechnology Inc, Annual Ratios
  • Puma Biotechnology Inc, Annual Ratios
  • Puma Biotechnology Inc, Interim Ratios
  • Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Puma Biotechnology Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Puma Biotechnology Inc, Performance Chart (2013 - 2017)
  • Puma Biotechnology Inc, Ratio Charts
  • Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Five Prime Therapeutics Inc
  • Fate Therapeutics Inc
  • Corcept Therapeutics Inc
  • Cascadian Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll